Abstract
Hyperleucocytosis is defined as a white cell count (WBC) >50 x 109/L or commonly 100 x 109/L in a patient with leukaemia. Hyperleucocytosis with leucostasis is most often seen in patients with Acute Myeloid leukaemia (AML). AML with hyperleucocytosis is thought to have a poor prognosis because of a higher risk of early death due to complications such as disseminated intravascular coagulation (DIC), tumour lysis syndrome (TLS), and leucostasis, as well as a higher likelihood of long-term relapse. Leucostasis is considered a medical emergency since it has the potential to cause ischemia in vital organs with high mortality requiring immediate intervention. The molecular mechanisms that cause hyperleucocytosis are not well known. The molecular mechanisms behind hyperleucocytosis remain poorly understood.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
